News and Press Releases

Epsilogen and Lonza Announce Successful Large-Scale GMP Manufacturing of MOv18, an IgE Antibody Targeting Ovarian Cancer

First time GMP manufacturing of a therapeutic IgE antibody has been achieved at scale GMP material to be used in phase 1b study in platinum-resistant ovarian cancer (PROC) patients scheduled...

Category: BioManufacturing
Posted: March 5, 2024

Waterfront, ARC West London, Manbre Road, Hammersmith, London, W6 9RH

Kite Presents New Data for Yescarta (axicabtagene ciloleucel) CAR T-cell Therapy Highlighting Manufacturing Excellence and Cost-Effectiveness in the US

Data Highlights Industry-leading Manufacturing Success Rates for US Axicabtagene Ciloleucel Patients from Launch to Present Data Also Supports Cost-effectiveness of Axicabtagene Ciloleucel Versus Bispecific Antibodies 16 February 2024 – Stockley...

Category: BioManufacturing
Posted: February 21, 2024

2400 Broadway Santa Monica, CA 90404

Global End-to-End Solutions Partner to Life Sciences Organisations, AscellaHealth, joins Manchester Science Park

20 February 2024 -- Manchester, UK -- Global healthcare and specialty pharmacy solutions company providing innovative solutions to life sciences and biotech manufacturers, AscellaHealth, is expanding its UK presence with...

Category: Manufacturing and Packing
Posted: February 20, 2024

AscellaHealth, LLC 1055 Westlakes Drive Suite 175 Berwyn, PA 19312, US